Anticytokine therapy for periodontal diseases: Where are we now?
about
Host modulation therapy: An indispensable part of perioceuticsDiacerein: A potential therapeutic drug for the management of experimental periodontitis in rats.Skin-on-a-chip model simulating inflammation, edema and drug-based treatmentFuture prospects of systemic host modulatory agents in periodontal therapy.Level-Specific Differences in Systemic Expression of Pro- and Anti-Inflammatory Cytokines and Chemokines after Spinal Cord Injury
P2860
Anticytokine therapy for periodontal diseases: Where are we now?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Anticytokine therapy for periodontal diseases: Where are we now?
@en
Anticytokine therapy for periodontal diseases: Where are we now?
@nl
type
label
Anticytokine therapy for periodontal diseases: Where are we now?
@en
Anticytokine therapy for periodontal diseases: Where are we now?
@nl
prefLabel
Anticytokine therapy for periodontal diseases: Where are we now?
@en
Anticytokine therapy for periodontal diseases: Where are we now?
@nl
P2093
P2860
P356
P1476
Anticytokine therapy for periodontal diseases: Where are we now?
@en
P2093
Maya Mhaske
P S Rakhewar
S S Doiphode
Yogesh Prakash Waykole
P2860
P356
10.4103/0972-124X.55837
P407
P577
2009-05-01T00:00:00Z